DrugPatentWatch Database Preview
Nostrum Labs Inc Company Profile
» See Plans and Pricing
What is the competitive landscape for NOSTRUM LABS INC, and what generic and branded alternatives to NOSTRUM LABS INC drugs are available?
NOSTRUM LABS INC has forty-eight approved drugs.
Summary for Nostrum Labs Inc
| US Patents: | 0 |
| Tradenames: | 42 |
| Ingredients: | 40 |
| NDAs: | 48 |
Drugs and US Patents for Nostrum Labs Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nostrum Labs Inc | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET;ORAL | 207587-003 | Mar 3, 2017 | DISCN | No | No | Start Trial | Start Trial | |||||
| Nostrum Labs Inc | MORPHINE SULFATE | morphine sulfate | SOLUTION;ORAL | 201011-002 | Feb 5, 2014 | DISCN | No | No | Start Trial | Start Trial | |||||
| Nostrum Labs Inc | RANITIDINE HYDROCHLORIDE | ranitidine hydrochloride | SYRUP;ORAL | 078684-001 | Aug 27, 2009 | DISCN | No | No | Start Trial | Start Trial | |||||
| Nostrum Labs Inc | NABUMETONE | nabumetone | TABLET;ORAL | 090427-002 | Dec 30, 2011 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
